All News
Opportunistic Infections with JAK inhibitors in RA
Winthrop and colleagues have reviewd the occurrence of opportunistic infections (OIs) associated with the use of Janus kinase (JAK) inhibitors in patients with rheumatoid arthritis (RA), showing that Herpez zoster (HZ) was the most common OI reported with JAK inhibitors in clinical trials, althou
Read Article
2022 EULAR Recommendations for Screening and Prophylaxis of Chronic and Opportunistic Infections
A EULAR Task force has developed recommendations for screening and prophylaxis of chronic and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases (AIIRD).
Read Article
Deprescribing in Older Adults w/ Rheumatic dz - When Less May Be More! Polypharmacy & multimorbidity are major problems in elderly. Deprescribing identifys problematic meds & tapering, stopping, D/C or withdrawing to maximize wellness https://t.co/vMTlp7SJjI https://t.co/sYkrjcouHM
Links:
Dr. John Cush RheumNow ( View Tweet)
Swedish study of Inflammatory bowel disease (IBD) pts w/ colorectal bx show that histological (aHR: 1.42 - 2.37) & clinical activity in IBD, especially UC (Not Crohns), were risk factors for preterm birth https://t.co/blGOjGxq70 https://t.co/xVvByFN2z1
Links:
Dr. John Cush RheumNow ( View Tweet)
Hear what KOLs are saying about #ACR22. We are featuring Drs: Michele Petri, Peter Nash, Artie Kavanaugh, Jack Cush. Follow us on Twitter and head to https://t.co/V10S4oVFsv for real-time coverage. https://t.co/u4GKfCYeTK
Links:
Dr. John Cush RheumNow ( View Tweet)
The spike protein of SARS-CoV-2 drives NLRP3 inflammasome activation (one of several reasons that patient may flare or activate after COVID-19 infection or vaccination?) https://t.co/92Z14bYaUD https://t.co/iEUSgPghtT
Dr. John Cush RheumNow ( View Tweet)
National Swedish Hip & Knee OA registry compared outcomes if pts seen in-person (F2F) or digitally (online) in 6946 pts - both groups improved at 3 mos; but digital pts had larger improvement at 3 mos (pain & Function) -- unknown if clinically meaningful https://t.co/yD4zAVpuhh https://t.co/IjqnTjXpbC
Links:
Dr. John Cush RheumNow ( View Tweet)
Undiagnosed RA During the Pandemic
The number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.
https://t.co/qEcEF8ukxm https://t.co/PcXAxrjT24
Links:
Dr. John Cush RheumNow ( View Tweet)
Full read review of advances in bone biology leading to drug development (denosumab, romosuzumab, Burosumab), advances in Pagets and rickets and key regulatory molecules for bone remodeling, RANK, RANKL, OPG, & sclerostin https://t.co/CMMzIrZRUa https://t.co/ABhaHxP8y2
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Patricia Harkins, @DrTrishHarkins, is new to the #ACR22 RheumNow reporter team.
From Dr. Harkins, "I am really looking forward to the new "Ignite sessions", as well as working with the Rheum Now Faculty for the first time!"
Follow her for real-time #ACR22 coverage! https://t.co/dpDfNJs1V4
Dr. John Cush RheumNow ( View Tweet)
"I can't wait to see how the new format works: the poster hall, the SPARK talks, and to see a whole lot of people in person!"
Follow Dr. David Liew, @drdavidliew, for real-time #ACR22 coverage! https://t.co/RBbLyqrBNT
Dr. John Cush RheumNow ( View Tweet)
Drug-induced Hepatotoxicity - many Rheum drugs on the list: Tylenol, azathioprine, allopurinol, cyclosporine, dapsone, gold, MTX, 6-MP, NSAIDs, ASA, SSZ, Minocin... https://t.co/tAaW41h7xS https://t.co/fn8sNbeslH
Links:
Dr. John Cush RheumNow ( View Tweet)
From the Crypt: Rheumatology Dead Word Cemetery
Arthritis, Rheumatic Disease and Rheumatology cover a catalogue of ageless disorders w/decades, if not centuries, of history behind them.Enjoy our blog on retired Rheum sayings, as so decreed by RheumNow.
https://t.co/WyBFEVa1h5 https://t.co/eE3HQ4N5Ia
Links:
Dr. John Cush RheumNow ( View Tweet)
2022 New Drug Approvals
Download today!
https://t.co/nz91Ckw0AZ https://t.co/QieTvcqjcy
Links:
Dr. John Cush RheumNow ( View Tweet)
One week away! #ACR22 https://t.co/bvFCfFpQom
Dr. John Cush RheumNow ( View Tweet)
“I am looking forward to the ACR to hear about the ground-breaking results from basic science to the new treatments. I am delighted to be part of the RheumNow faculty covering the many topics from #ACR22. “
Follow Dr. Chan at @synovialjoints for real-time coverage of #ACR22. https://t.co/i6OZRHlBaE
Dr. John Cush RheumNow ( View Tweet)
New regulatory decisions about JAK inhibitors and why do women with rheumatic diseases have unfair outcomes?
This and more on the latest RheumNow podcast.
https://t.co/4YBqHjI3VL https://t.co/g2pE72pyEk
Links:
Dr. John Cush RheumNow ( View Tweet)
“At the ACR I am looking forward to meeting colleagues in person, having some great food in Philadelphia and to learning alot as a RheumNow reporter!”
Dr. Janet Pope is back for #ACR22 as a RheumNow reporter, sharing real-time coverage on many topics. Follow her @Janetbirdope https://t.co/ROD7oan4KZ
Dr. John Cush RheumNow ( View Tweet)
SLE T2T - Lupus Low Disease Activity State Predicts Outcomes
A prospective study shows that T2T with a goal of LLDAS and remission has been shown to improve mortality risk.
https://t.co/WRaqjdVi9G https://t.co/3guKt0Qby9
Links:
Dr. John Cush RheumNow ( View Tweet)
2022 CDC Clinical Practice Guideline on Opioid Prescribing
The CDC has updated its Guideline for Prescribing Opioids for Chronic Pain and includes recommendations for managing acute, subacute, and chronic pain.
https://t.co/aFE4fUpIWn https://t.co/kG8QlVy2bG
Links:
Dr. John Cush RheumNow ( View Tweet)